Arrhythmias & electrophysiology

Role of serotonin and serotonergic-related metabolites in the pathogenesis of vasovagal syncope

Heart RhythmPublished Mechanistic study

Authors' conclusion

Despite the unchanged plasma and platelet serotonin levels, certain serotonergic-related metabolites significantly changed and correlated with hemodynamic parameters during VVS episodes

Study context

Population
Patients with recurrent vasovagal syncope undergoing head-up tilt testmean age 45.6±17.0 years
Participants
66 patients
Comparison
Head-up tilt test (HUTT)-positive vs HUTT-negative patients; before vs during syncope
  • HUTT-positiven = 45
  • HUTT-negativen = 21reference
Outcome
Plasma and platelet serotonin and plasma serotonergic-related metabolites (5-HTP, 5-hydroxyindoleacetic acid, tryptophan)
Follow-up
Resting supine and, in HUTT-positive patients, during syncope

Main finding

As reported in the abstract

Plasma 5-HTP differed between HUTT-positive and HUTT-negative
P<.001
Plasma 5-hydroxyindoleacetic acid differed between HUTT-positive and HUTT-negative
P=.040
5-HTP and 5-hydroxyindoleacetic acid differed before vs after syncope
P<.001 for all
Plasma serotonin increased during syncope in drug-free VVS
P=.037
Greater serotonin change correlated with shorter time to syncope
R2=0.38; P=.015

Original publication

Role of serotonin and serotonergic-related metabolites in the pathogenesis of vasovagal syncope. Heart Rhythm. Published 21 September 2024. doi:10.1016/j.hrthm.2024.09.047

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.